Concord Medical Co (ROCO:6518) Marketable Securities: NT$97 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6518 Concord Medical Co Ltd ROCO:6518
74 GF Score
Price NT$32.60
GF Value NT$31.22
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Concord Medical Co Marketable Securities?

Concord Medical Co ROCO:6518 +5.16% 74 Marketable Securities is NT$97 Mil as of Jun. 2026. GuruFocus rates ROCO:6518 with a GF Score™ of 74/100 and a GF Value™ of NT$31.22 (Fairly Valued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Concord Medical Co's Marketable Securities for the quarter that ended in Jun. 2026 was NT$97 Mil.

Concord Medical Co's annual Marketable Securities increased from Dec. 2023 (NT$209 Mil) to Dec. 2024 (NT$212 Mil) but then declined from Dec. 2024 (NT$212 Mil) to Dec. 2025 (NT$158 Mil).

Concord Medical Co  (ROCO:6518) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Concord Medical Co Marketable Securities Related Terms

Concord Medical Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Concord Medical Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Medical Co Marketable Securities Chart

Concord Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.77 100.00 209.00 211.50 158.00

Concord Medical Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 205.50 211.50 136.00 158.00 97.00
ROCO:6518
74GF Score
Concord Medical Co Ltd ROCO:6518
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Concord Medical Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$97 Mil mean?
Concord Medical Co (ROCO:6518) has a Marketable Securities of NT$97 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Concord Medical Co and its competitors.
Is Concord Medical Co's Marketable Securities too high?
Concord Medical Co's current Marketable Securities is NT$97 Mil. Overall, Concord Medical Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Co's Marketable Securities compare to ISRG and BDX?
Concord Medical Co's Marketable Securities of NT$97 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Concord Medical Co and its competitors. Concord Medical Co's current Marketable Securities is NT$97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Concord Medical Co (ROCO:6518) is currently considered Fairly Valued. The stock's GF Value™ is NT$31.22, compared to a current price of NT$32.60 — trading 4.4% above its estimated fair value. The current Marketable Securities is NT$97 Mil. Concord Medical Co's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Concord Medical Co (ROCO:6518), the current Marketable Securities is NT$97 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Concord Medical Co (ROCO:6518) Overvalued in 2026?

Based on GuruFocus' analysis, Concord Medical Co stock appears to be overvalued. The current stock price of NT$32.60 is trading 4.4% above its estimated GF Value™ of NT$31.22. GuruFocus considers Concord Medical Co to be Fairly Valued.

Key valuation signals for ROCO:6518:

  • Marketable Securities: NT$97 Mil
  • GF Value™: NT$31.22 vs. price of NT$32.60 (4.4% above fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Concord Medical Co Business Description

Address Number 266, Wenhua Road, 12F, Sec.1, 12th Floor, Banqiao District, New Taipei City, Taipei, TWN, 22041
Concord Medical Co Ltd is a Taiwan based company involved in providing hospital management support services including medical equipment leasing, pharmaceuticals, and medical consumables integrated supply. . The company's main business items are medical equipment, pharmaceuticals Product trading business, leasing business and management consulting services.
74GF Score

Get the complete analysis for ROCO:6518

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$32.60
Price
NT$31.22
GF Value